The discrepancy could be due to the animal model used, because the APP/PS1 mouse model only recapitulates Aβ pathology (with little tau pathology or neuronal loss), and hence mainly reflects the early stage of AD. This evidence concerns the gene MAPT and Alzheimer disease.